REVB
REVB
NASDAQ · Biotechnology

Revelation Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.03
-0.01 (-0.96%)
As of Jun 30, 11:00 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +891.3% upside
Low Target $7.91
Average Target $10.21
High Target $15.75
Current Price $1.03
Current
$1.03
Target
$10.21
$7.91 $10.21 avg $15.75
Scenario Analysis
Bear Case
$7.91
668.0%
Low target
Base Case
$10.21
+891.3%
Avg target
Bull Case
$15.75
+1,429.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.88
-92.0% from high
52-Week Low
$0.88
+17.7% from low
Target vs 52W High
$10.21
-20.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%